Scibetta James S
SEC-identified person · CIK 1383242 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Matinas Biopharma Holdings, Inc. MTNB] | Director | filed 2017 - 2023 |
| Aquestive Therapeutics, Inc. AQST | Director | filed 2018 - 2021 |
| Pacira Pharmaceuticals, Inc. PCRX | SVP, Chief Financial Officer | filed 2011 - 2017 |
| Nephros INC NEPHD | Director | filed 2007 - 2014 |
| Bioenvision INC BIVN | Chief Financial Officer | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.